Position in INCY
as of Jun 30, 2026
· filed Aug 10, 2026
Position Value
$7,687,395
+$2,951,842 QoQ
Shares Held
67,814
+34.8% QoQ
Ownership
0.034%
of shares outstanding
% of Portfolio
0.04%
of 13F equity value
Holder Rank
#183
of 849 holders
Holding Since
Mar 2020
19 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in INCY Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Tredje AP-fonden holds $108,189,503 across 9 Biotechnology names. INCY ranks #5 (7.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | REGN |
Regeneron Pharmaceuticals, Inc.
|
48,079 | $29,979,179 | |
| 2 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
59,459 | $29,535,069 | |
| 3 | RPRX |
Royalty Pharma plc
|
219,990 | $12,334,839 | |
| 4 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
37,206 | $11,200,122 | |
| 5 | INCY |
Incyte Corp
This page
|
67,814 | $7,687,395 | |
| 6 | ASND |
Ascendis Pharma A/S
|
20,448 | $5,453,890 | |
| 7 | RVMD |
Revolution Medicines, Inc.
|
27,000 | $5,056,560 | |
| 8 | BMRN |
Biomarin Pharmaceutical Inc
|
60,944 | $3,487,215 |
All Filings in INCY
Export CSV
19 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $7,687,395 | 67,814 | Shares | Sole | 2026-08-10 | |
| 2026-03-31 | $4,735,553 | 50,314 | Shares | Sole | 2026-05-12 | |
| 2025-12-31 | $5,217,031 | 52,820 | Shares | Sole | 2026-02-06 | |
| 2025-09-30 | $1,520,897 | 17,933 | Shares | Sole | 2025-11-10 | |
| 2025-06-30 | $1,178,266 | 17,302 | Shares | Sole | 2025-08-05 | |
| 2025-03-31 | $898,864 | 14,845 | Shares | Sole | 2025-05-08 | |
| 2024-12-31 | $1,025,344 | 14,845 | Shares | Sole | 2025-02-10 | |
| 2024-09-30 | $1,962,442 | 29,689 | Shares | Sole | 2024-11-08 | |
| 2024-06-30 | $1,799,747 | 29,689 | Shares | Sole | 2024-08-12 | |
| 2024-03-31 | $1,718,044 | 30,157 | Shares | Sole | 2024-05-13 | |
| 2023-12-31 | $1,893,558 | 30,157 | Shares | Sole | 2024-02-12 | |
| 2023-09-30 | $1,807,912 | 31,295 | Shares | Sole | 2023-11-09 | |
| 2023-06-30 | $2,129,385 | 34,207 | Shares | Sole | 2023-08-11 | |
| 2023-03-31 | $2,897,954 | 40,099 | Shares | Sole | 2023-05-10 | |
| 2022-12-31 | $3,069,910 | 38,221 | Shares | Sole | 2023-02-10 | |
| 2022-09-30 | $2,476,009 | 37,155 | Shares | Sole | 2022-11-10 | |
| 2020-09-30 | $1,196,413 | 13,332 | Shares | Sole | 2020-11-10 | |
| 2020-06-30 | $1,386,128 | 13,332 | Shares | Sole | 2020-08-11 | |
| 2020-03-31 | $976,302 | 13,332 | Shares | Sole | 2020-05-28 | |
| No filing history on record for this holder in this stock. | ||||||